You Eat Clean. You Exercise. And It's Still High.
A cardiologist on why diet and willpower only move cholesterol so far, what is actually building inside the artery wall, and the research most people are never pointed toward.
The Most Frustrating Lab Result There Is
There is a specific kind of frustration that comes with a high cholesterol number when you have done everything right. You cut the red meat. You walk. You are not overweight. And the number came back high anyway.
I hear it constantly. "I eat clean and it is still high." And the honest answer is one that does not get said enough: for a lot of people, cholesterol is heavily genetic. Diet and exercise matter, but they are not the whole story, and willpower cannot override family wiring. That is not a personal failure. It is biology.
So the number sits there. And usually the next conversation is about a statin.
Why So Many People Hesitate on the Pill
If you would rather not start a statin, you are far from alone, and your reasons are worth taking seriously. Some people tolerate them perfectly well. Others report muscle aches, fatigue, or a foggy feeling, and many simply do not want to begin a medication they may take for the rest of their life.
For some people, especially those with very high or inherited cholesterol, medication is genuinely the right and necessary choice. Nothing here is a reason to refuse or stop a medication your doctor has prescribed. This is about what you can do alongside their guidance.
What most people are never told is that the cholesterol number on the page is not the whole danger. The danger is what that cholesterol slowly does inside the artery wall. And lowering the number does not clear what has already built up there.
The Number Is Not the Buildup
Over the years, cholesterol, calcium, and other material layer into the artery wall as plaque. Woven through that buildup is fibrin, a tough, sticky protein the blood uses to form clots. It is part of what holds the structure together.
Here is the part that reframes everything. Lowering your cholesterol number slows new material from arriving. It does not break down the structural buildup that has been layering on for decades. That existing buildup needs a different mechanism entirely, one that almost nothing in the standard toolkit was designed to address.
A Japanese Enzyme Studied for That Buildup
Nattokinase is an enzyme from natto, a traditional Japanese fermented food. It is studied specifically for supporting the body's natural ability to break down fibrin, the protein woven through arterial buildup.
In the Chen 2022 trial of over a thousand adults, the group taking a clinical-level dose over twelve months saw measurable reduction in arterial plaque on ultrasound, with cholesterol and blood pressure markers improving alongside it. The lower-dose group saw little. The difference was the dose.
A note of honesty this audience deserves: nattokinase on its own is not a cholesterol-lowering agent the way a statin is, and you should be skeptical of anything that claims otherwise. What the research points to is something different and arguably more interesting. Support for the structure inside the artery wall, not just the number on the lab sheet.
Why Most Nattokinase Does Nothing
Two things decide whether it works, and most products miss both.
Dose. Most bottles are 2,000 FU. The research used far more. FU, fibrinolytic units, is the number that matters, not the milligrams printed on the front.
Survival. Nattokinase is a protein, and stomach acid destroys proteins. A standard capsule is gone before it reaches the small intestine. Enteric coating is what gets it through. If the label does not say enteric-coated, assume it is not.
The Formula Built on the Dose That Worked
The product I point patients toward is Hale Heart, built to be used alongside your doctor's guidance, never instead of it.
10,000 FU of nattokinase per serving, enteric coated. With CoQ10, the nutrient the heart muscle runs on and the one statin users most often look to replace. Plus bromelain, turmeric, ginger, and olive leaf.
Every ingredient on the label with its exact dose. Third-party tested. No proprietary blends. Enteric-coated capsules designed to deliver the enzyme past stomach acid intact.
What People Are Telling Me
- Chen H, et al. (2022). Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants. Frontiers in Cardiovascular Medicine, 9, 964977.
- Li D, et al. (2023). Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Reviews in Cardiovascular Medicine, 24(8), 234.
- Ren NN, et al. (2017). A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia. Zhonghua Yi Xue Za Zhi, 97(26), 2038-2042.
- Sumi H, et al. (1990). Enhancement of the Fibrinolytic Activity in Plasma by Oral Administration of Nattokinase. Acta Haematologica, 84(3), 139-143.
